Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 57

From Domain	Role	To Domain	Path
ksqtx.com	>>isReferenceFrom	tilworkinggroup.com	/sponsors/
ksqtx.com	>>isReferenceFrom	itresearchbrief.com	/ksq-therapeutics-indicates-identification-validation-of-ct-1
ksqtx.com	>>isReferenceFrom	zagbio.com	/our-team/about-us/
ksqtx.com	>>isReferenceFrom	coe.northeastern.edu	/news/integrating-data-analytics-and-bioengineering-to-enhance-lives/
ksqtx.com	>>isReferenceFrom	massbio.org	/news/recent-news/member-spotlight-qa-with-ksq-therapeutics/
ksqtx.com	>>isReferenceFrom	gene.com	/partners/what-we-are-looking-for/oncology-and-hematology
ksqtx.com	>>isReferenceFrom	bioe.northeastern.edu	/news/integrating-data-analytics-and-bioengineering-to-enhance-lives/
ksqtx.com	>>isReferenceFrom	mie.northeastern.edu	/news/integrating-data-analytics-and-bioengineering-to-enhance-lives/
ksqtx.com	>>isReferenceFrom	alphawaveglobal.com	/businesses/ventures-incubation
ksqtx.com	>>isReferenceFrom	crisp-bio.blog.jp	/archives/39290444.html
ksqtx.com	>>isReferenceFrom	ctmc.com	/partnerships-collaborations/
sec.gov	>>isReferenceFrom	ksqtx.com	/press-releases/crispr-therapeutics-and-ksq-therapeutics-announce-license-agreement-to-advance-companies-respective-cell-therapy-programs-in-oncology/
crisprtx.com	>>isReferenceFrom	ksqtx.com	/press-releases/crispr-therapeutics-and-ksq-therapeutics-announce-license-agreement-to-advance-companies-respective-cell-therapy-programs-in-oncology/
maxcyte.com	>>isReferenceFrom	ksqtx.com	/press-releases/maxcyte-and-ksq-therapeutics-announce-development-and-commercialization-agreement-to-enable-the-advancement-of-ksqs-adoptive-cell-therapy-programs/
eortc.org	>>isReferenceFrom	ksqtx.com	/press-releases/ksq-therapeutics-to-present-new-data-from-its-usp1-inhibitor-program-at-upcoming-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics/
event.eortc.org	>>isReferenceFrom	ksqtx.com	/press-releases/ksq-therapeutics-presents-first-preclinical-data-for-ksq-4279-a-novel-usp1-inhibitor-for-the-treatment-of-brca-deficient-cancers/
ono-pharma.com	>>isReferenceFrom	ksqtx.com	/press-releases/ksq-therapeutics-announces-ono-pharmaceutical-co-ltd-is-acquiring-multiple-research-stage-oncology-programs-identified-with-ksqs-crispromics-platform-technology/
globenewswire.com	>>isReferenceFrom	ksqtx.com	/press-releases/ksq-therapeutics-and-ctmc-announce-strategic-collaboration-to-accelerate-the-development-of-novel-engineered-tumor-infiltrating-lymphocyte-etil-therapies-for-the-treatment-of-solid-tumors/
faculty.mdanderson.org	>>isReferenceFrom	ksqtx.com	/press-releases/ksq-therapeutics-announces-first-patient-dosed-in-phase-1-2-study-for-ksq-004ex-a-crispr-cas9-engineered-tumor-infiltrating-lymphocyte-etil-therapy/
boards.greenhouse.io	>>isReferenceFrom	ksqtx.com	/careers/

1 2 3 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "ksqtx.com"

BR-Relations: 57